Shumin Ma
Impact in
-
- Hepatitis C virus research
-
- Inflammasome and immune disorders
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
Papers in
-
- Protein Degradation and Inhibitors 7
- Ubiquitin and proteasome pathways 5
- RNA modifications and cancer 3
- Inflammasome and immune disorders 3
- Oncology 11
- Peptidase Inhibition and Analysis 6
- Co-authors
- Shijun Chen (3 shared papers)Wenjun Du (2 shared papers)Junhui Zhen (2 shared papers)Chong Qin (10 shared papers)Zhixue Liu (4 shared papers)Le Zhang (1 shared paper)Zheng‐Xiang Li (1 shared paper)Zhaomin Zheng (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (8 papers)Oxidative Medicine and Cellular Longevity (1 paper)Clinical Genetics (1 paper)Cellular and Molecular Neurobiology (1 paper)The International Journal of Biochemistry & Cell Biology (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Shumin Ma
30 papers receiving 289 citations
Peers
Comparison fields: 5 of 65
- Hepatology 28
- Molecular Biology 202
- Physiology 11
- Immunology 51
- Nephrology 17
Countries citing papers authored by Shumin Ma
This map shows the geographic impact of Shumin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shumin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shumin Ma more than expected).
Fields of papers citing papers by Shumin Ma
This network shows the impact of papers produced by Shumin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shumin Ma. The network helps show where Shumin Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Shumin Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 54 | |
| 2 | 2023 | 29 | |
| 3 | 2023 | 22 | |
| 4 | 2018 | 21 | |
| 5 | 2013 | 20 | |
| 6 | 2016 | 20 | |
| 7 | 2018 | 12 | |
| 8 | 2021 | 11 | |
| 9 | 2016 | 11 | |
| 10 | 2013 | 11 | |
| 11 | 2024 | 10 | |
| 12 | 2023 | 10 | |
| 13 | 2021 | 9 | |
| 14 | 2024 | 7 | |
| 15 | 2021 | 6 | |
| 16 | 2021 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2018 | 6 | |
| 19 | 2019 | 4 | |
| 20 | 2023 | 3 |
About Shumin Ma
Shumin Ma is a scholar working on Molecular Biology, Oncology, Epidemiology, Cell Biology and Hepatology, having authored 32 papers that have together received 292 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (7 papers), Peptidase Inhibition and Analysis (6 papers), Ubiquitin and proteasome pathways (5 papers), Hepatitis B Virus Studies (3 papers), RNA modifications and cancer (3 papers), Multiple Myeloma Research and Treatments (3 papers), Autophagy in Disease and Therapy (3 papers) and Inflammasome and immune disorders (3 papers). The work is most often cited by research in Hepatology (28 citations), Molecular Biology (202 citations), Physiology (11 citations), Immunology (51 citations) and Nephrology (17 citations). Shumin Ma has collaborated with scholars based in China, United States and France. Frequent co-authors include Shijun Chen, Wenjun Du, Junhui Zhen, Chong Qin, Zhixue Liu, Le Zhang, Zheng‐Xiang Li, Zhaomin Zheng, Siqi Zhang and Wenwen Luo. Their work appears in journals such as Journal of Medicinal Chemistry, Oxidative Medicine and Cellular Longevity, Clinical Genetics, Cellular and Molecular Neurobiology and The International Journal of Biochemistry & Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.